These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 33291429)

  • 21. Peri-implantitis in partially edentulous patients: association with inadequate plaque control.
    Serino G; Ström C
    Clin Oral Implants Res; 2009 Feb; 20(2):169-74. PubMed ID: 19077152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors related to peri-implantitis - a retrospective study.
    Renvert S; Aghazadeh A; Hallström H; Persson GR
    Clin Oral Implants Res; 2014 Apr; 25(4):522-9. PubMed ID: 23772670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does chlorhexidine improve outcomes in non-surgical management of peri-implant mucositis or peri-implantitis?: a systematic review and meta-analysis.
    Liu S; Li M; Yu J
    Med Oral Patol Oral Cir Bucal; 2020 Sep; 25(5):e608-e615. PubMed ID: 32683389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long time follow up of implant therapy and treatment of peri-implantitis.
    Roos-Jansåker AM
    Swed Dent J Suppl; 2007; (188):7-66. PubMed ID: 17694834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and predictive factors for peri-implant disease and implant failure: a cross-sectional analysis.
    Daubert DM; Weinstein BF; Bordin S; Leroux BG; Flemming TF
    J Periodontol; 2015 Mar; 86(3):337-47. PubMed ID: 25415249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peri-implant mucositis and peri-implantitis: clinical and histopathological characteristics and treatment.
    Khammissa RA; Feller L; Meyerov R; Lemmer J
    SADJ; 2012 Apr; 67(3):122, 124-6. PubMed ID: 23198360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of peri-implant diseases: a review of the literature and protocol proposal.
    Armas J; Culshaw S; Savarrio L
    Dent Update; 2013; 40(6):472-4, 476-8, 480. PubMed ID: 23971346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Restorative design and associated risks for peri-implant diseases.
    Dixon DR; London RM
    Periodontol 2000; 2019 Oct; 81(1):167-178. PubMed ID: 31407441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peri-implant health, peri-implant mucositis, and peri-implantitis: Case definitions and diagnostic considerations.
    Renvert S; Persson GR; Pirih FQ; Camargo PM
    J Periodontol; 2018 Jun; 89 Suppl 1():S304-S312. PubMed ID: 29926953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peri-implant health, peri-implant mucositis, and peri-implantitis: Case definitions and diagnostic considerations.
    Renvert S; Persson GR; Pirih FQ; Camargo PM
    J Clin Periodontol; 2018 Jun; 45 Suppl 20():S278-S285. PubMed ID: 29926496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Th17-related cytokines in mucositis: is there any difference between peri-implantitis and periodontitis patients?
    Teixeira MKS; Lira-Junior R; Telles DM; Lourenço EJV; Figueredo CM
    Clin Oral Implants Res; 2017 Jul; 28(7):816-822. PubMed ID: 27283128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Occurrence of cases with peri-implant mucositis or peri-implantitis in a 21-26 years follow-up study.
    Renvert S; Lindahl C; Persson GR
    J Clin Periodontol; 2018 Feb; 45(2):233-240. PubMed ID: 28963776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Active Matrix Metalloproteinase-8 (aMMP-8) Versus Total MMP-8 in Periodontal and Peri-Implant Disease Point-of-Care Diagnostics.
    Räisänen IT; Aji NRAS; Sakellari D; Grigoriadis A; Rantala I; Pätilä T; Heikkilä P; Gupta S; Sorsa T
    Biomedicines; 2023 Oct; 11(11):. PubMed ID: 38001886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Ability of Quantitative, Specific, and Sensitive Point-of-Care/Chair-Side Oral Fluid Immunotests for aMMP-8 to Detect Periodontal and Peri-Implant Diseases.
    Alassiri S; Parnanen P; Rathnayake N; Johannsen G; Heikkinen AM; Lazzara R; van der Schoor P; van der Schoor JG; Tervahartiala T; Gieselmann D; Sorsa T
    Dis Markers; 2018; 2018():1306396. PubMed ID: 30154936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peri-Implant Sulcus Fluid (PISF) Matrix Metalloproteinase (MMP) -8 Levels in Peri-Implantitis.
    Thierbach R; Maier K; Sorsa T; Mäntylä P
    J Clin Diagn Res; 2016 May; 10(5):ZC34-8. PubMed ID: 27437357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of Peri-Implant Diseases: A Survey of Australian Periodontists.
    Khan A; Sharma D
    Dent J (Basel); 2020 Sep; 8(3):. PubMed ID: 32882900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of factors related to periodontal status toward peri-implantitis.
    Arunyanak SP; Sophon N; Tangsathian T; Supanimitkul K; Suwanwichit T; Kungsadalpipob K
    Clin Oral Implants Res; 2019 Aug; 30(8):791-799. PubMed ID: 31107993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Active MMP-8 as a Biomarker of Peri-implant Health or Disease.
    Xanthopoulou V; Räisänen I; Sorsa T; Sakellari D
    Eur J Dent; 2023 Jul; 17(3):924-928. PubMed ID: 36063841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative biology of chronic and aggressive periodontitis vs. peri-implantitis.
    Heitz-Mayfield LJ; Lang NP
    Periodontol 2000; 2010 Jun; 53():167-81. PubMed ID: 20403112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Occurrence of peri-implant diseases and risk indicators at the patient and implant levels: A multilevel cross-sectional study.
    Pimentel SP; Shiota R; Cirano FR; Casarin RCV; Pecorari VGA; Casati MZ; Haas AN; Ribeiro FV
    J Periodontol; 2018 Sep; 89(9):1091-1100. PubMed ID: 29761866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.